Cipher Pharmaceuticals (TSE:CPH) Stock Price Crosses Above 50 Day Moving Average – Here’s Why

Cipher Pharmaceuticals Inc. (TSE:CPHGet Free Report) (NASDAQ:CPHR)’s stock price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$15.16 and traded as high as C$16.90. Cipher Pharmaceuticals shares last traded at C$16.83, with a volume of 18,162 shares changing hands.

Cipher Pharmaceuticals Price Performance

The firm has a market capitalization of C$425.48 million, a price-to-earnings ratio of 16.03 and a beta of 1.33. The stock’s fifty day moving average price is C$15.16 and its two-hundred day moving average price is C$14.99. The company has a current ratio of 1.12, a quick ratio of 2.67 and a debt-to-equity ratio of 4.36.

About Cipher Pharmaceuticals

(Get Free Report)

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.

Featured Stories

Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.